Rising patient interest in peptides like BPC-157 and TB-500 for musculoskeletal recovery, often fueled by online hype
Regular reviews of all medications by healthcare providers, including nephrologists and pharmacists, are vital
Studies in mammals show that ghrelin also stimulates growth hormone (GH) secretion from the pituitary (hence the name, g rowth h ormone- rel easing peptide), thereby increasing adiposity and reducing energy expenditure and that that ghrelin level is linked to stomach filling and the anticipation of a meal (partly as a conditional response) and meal initiation (Howick et al., 2017)
Most existing data are correlational, often based on indirect markers such as systemic cytokines or peripheral hormone levels
The Bottom Line As I navigate this space with my patients, I hold two truths simultaneously: the preclinical evidence for certain peptides is genuinely compelling, AND the lack of rigorous human safety data demands significant caution